Neuropathic pain - Pathophysiological concepts, predictors and new therapies;Neuropathische schmerzen - Pathophysiologische konzepte, pradiktoren und neue therapieansatze

Aktuelle Neurologie

Volumn 24, Issue 3, 1997, Pages 94-102

  Baron, R ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; CAPSAICIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CENTRAL NERVOUS SYSTEM; HUMAN; NEUROPATHY; NOCICEPTION; PAIN; PATHOPHYSIOLOGY; PERIPHERAL NERVE INJURY; PREDICTION; SPINAL CORD DORSAL HORN; SYMPATHETIC BLOCKING;

EID: 0030814425     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1017789     Document Type: Article

References (56)

1. Ahlgren, S. C., J. D. Levine: Mechanical hyperalgesia in streptozotocin-diabetic rats. Neuroscience 52 (1993) 1049-1055
2. Andreev, N. Y., N. Dimitrieva, M. Koltzenburg et al.: Peripheral administration of nerve growth factor in adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones. Pain 63 (1995) 109-115
3. Anér, S., B. A. Meyerson: Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33 (1988) 11-23
4. Apfel, S. C., J. C. Arezzo, M. Brownlee: Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 634 (1994) 7-12
5. Averill, S., S. B. McMahon, D. O. Clary et al.: Immunocytochemical localisation of trkA receptors in chemically identified subgroups of adult sensory neurones. Eur. J. Neurosci. 7 (1995) 1484-1494
6. Baron, R.: Schmerzsyndrome bei Erkrankungen peripherer Nerven. Nervenheilkunde 10 (1991) 88-92
7. Baron, R.: Schmerzsyndrome bei peripheren Neuropathien. Internist. Praxis 33 (1993) 107-1202
8. Baron, R., H. Blumberg, W. Jänig: Clinical characteristics of patients with complex regional pain syndromes in Germany with special emphasis on vasomotor function. In: Jänig, W., M. Stanton-Hicks (eds.): Progress in Pain Research and Management, Vol. 6, Reflex Sympathetic Dystrophy - a Reappraisal. IASP Press, Seattle (1996) 25-48
9. Baron, R., G. Haendler, H. Schulte: Generalized subclinical impairment of myelinated afferents predicts the development of postherpetic neuralgia. Abstract 8th World Congress on Pain. Vancouver BC. IASP Press, Seattle (1996)
10. Baron, R., C. Maier: Reflex sympathetic dystrophy: Skin blood flow, sympathetic vasoconstrictor reflexes and pain before and after surgical sympathectomy. Pain (im Druck)
11. Baron, R., C. Maier: Painful neuropathy: C-nociceptor activity may not be necessary to maintain central mechanisms accounting for dynamic mechanical allodynia. Clin. J. Pain 11 (1995) 63-69
12. Baron, R., M. Saguer: Postherpetic neuralgia: Are C-nociceptors involved in signalling and maintenance of tactile allodynia? Brain 116 (1993) 1477-1496
13. Baron, R., M. Saguer: Mechanical allodynia in postherpetic neuralgia: Evidence for central mechanisms depending on nociceptive C-fiber degeneration. Neurology 45, Suppl. 8 (1995) S63-S65
14. Blumberg, H., W. Jänig: Discharge pattern of afferent fibers from a neuroma. Pain 20 (1984) 335-353
15. Bonica, J. J.: Causalgia and other reflex sympathetic dystrophies. In: Bonica, J. J. (ed.): The Management of Pain, 2. ed. Lea and Febiger, Philadelphia (1990) 220-243
16. Campbell, J. N., R. A. Meyer, S. N. Raja: Is nociceptor activation by α-1 adrenoreceptors the culprit in sympathetically maintained pain? APS J. 1 (1992) 3-11
17. Cline, M. A., J. Ochoa, H. E. Torebjörk: Chronic hyperalgesia and skin warming caused by sensitized C nociceptors. Brain 112 (1989) 621-647
18. Crowley, C., S. D. Spencer, M. C. Nishimura et al.: Mice lacking nerve growth factor display perimatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76 (1994) 1001-1011
19. Devor, M., P. D. Wall, N. Catalan: Systemic lignocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 48 (1992) 261-268
20. Devor, M., W. Jänig: Activation of myelinated afferents ending in a neuroma by stimulation of the sympathetic supply in the rat. Neurosci. Lett. 24 (1981) 43-47
21. Eide, P. K., A. Stubhaug, I. Oye et al.: Continuous subcutaneous administration of N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 61 (1995) 221-228
22. Häbler, H.-J., W. Jänig, M. Koltzenburg: Activation of unmyelinated afferents in chronically lesioned nerves by adrenaline and excitation sympathetic efferents in the cat. Neurosci. Lett. 82 (1987) 35-40
23. Heumann, R., S. Korschnig, C. Bandtlow et al.: Changes of nerve growth factor synthesis in nonneural cells in response to sciatic nerve transection. J. Cell. Biol. 104 (1987) 1623-1631
24. Jänig, W: Sympathikus und Schmerz: Ideen, Hypothesen, Modelle. Der Schmerz 7 (1993) 226-240
25. Jänig, W., M. Koltzenburg: Possible ways of sympathetic afferent interactions. In: Jänig, W., R. F. Schmidt (eds.): Reflex Sympathetic Dystrophy. Pathophysiological Mechanisms and Clinical Implications. VCH Verlagsgesellschaft, Weinheim, New York (1992) 213-245
26. Juma, I., M. Zenz: Antikonvulsiva beim Nervenschmerz. Der Schmerz 6 (1992) 146-149
27. Kishore-Kumar, R., M. B. Max, S. C. Schafer et al.: Desipramine relieves postherpetic neuralgia. Clin. Pharmacol. Ther. 47 (1990) 305-312
28. Lewin, G. R., A. Rueff, L. M. Mendell: Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur. J. Neurosci 6 (1994) 1903-1912
29. Lindholm, D., R. Heumann, M. Meyer et al.: Interleukin I regulates synthesis of nerve growth factor in non-neural cells of rat sciatic nerve. Nature 330 (1987) 658-659
30. Max, M. B., R. Kishore-Kumar, S. C. Schafer et al.: Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 45 (1991) 3-9
31. Mc Lachlan, E. M., W. Jänig, M. Devor et al.: Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature 363 (1993) 543-545
32. Mellick, G. A., L. B. Mellicy, L. B. Mellick: Gabapentin in the management of reflex sympathetic dystrophy, J. Pain Symptom. Manag 10 (1995) 265-266
33. Meyer, G. A., H. L. Fields: Causalgia treated by selective large fibre stimulation of peripheral nerve. Brain 95 (1972) 163-168
34. Nagy, I., C. J. Woolf: Lignocaine selectively reduces C fibre-evoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptor-mediated postsynaptic depolarizations; implications for the development of novel centrally acting analgesics. Pain 64 (1996) 59-70
35. Nakamura-Craig, M., R. L. Follenfant: Effect of lamotrigine in acute and chronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes. Pain 63 (1995) 33-37
36. Persson, J., G. Axelsson, R. Hallin et al.: Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization. Pain 60 (1995) 217-222
37. Portenoy, R. K., K. M. Foley, C. A. Inturrisi: The nature of opioid responsiveness and its implication for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 43 (1990) 273-286
38. Raivich, G., R. Hellweg, G. W. Kreutzberg: NGF receptor-reduction in axonal NGF uptake and retrograde transport following sciatic nerve injury and during regeneration. Neuron 7 (1991) 151-164
39. Rowbotham, M. C., L. A. Reissner-Keller, H. L. Fields: Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 41 (1991) 1024-1028
40. Rowbotham, M. C. P. S. Davies, H. L. Fields: Topical lidocaine gel relieves postherpetic neuralgia. Ann. Neurol. 37 (1995) 246-253
41. Sato, J., E. R. Perl: Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science 251 (1991) 1608-1610
42. Swerdlow, M.: Anticonvulsant drugs and chronic pain. Clin. Neuropharmacol. 7 (1984) 51-82
43. Thompson, S. W. N., A. Dray, K. E. McCarson et al.: Nerve growth factor induces mechanical allodynia associated with novel A fibre-evoked spinal reflex activity and enhanced neurokinin-1 receptor activation in the rat. Pain 62 (1995) 219-231
44. Watson, C. P. N., M. Chipman, K. Reed et al.: Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, doubleblind, crossover trial. Pain 48 (1992) 29-36
45. Watson, C. P., R. J. Evans, V. R. Watt: Postherpetic neuralgia and topical capsaicin. Pain 33 (1988) 333-340
46. Woolf, C. J., P. Shortland, R. E. Coggeshall: Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 355 (1992) 75-78
47. Wolf, C. J., B. Safieh-Garabedian, P. Q. Ma et al.: Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 62 (1994) 327-331
48. Baron, R.: Pathophysiological mechanisms in postherpetic neuralgia. The Pain Clinic 9 (1996) 217-233
49. Bennett, G. J.: Neuropathic Pain. In: Wall, P. D., R. Melzack (eds.): Textbook of Pain, 3. ed. Churchill, Livingstone (1994) 201-224
50. Brewster, W. J. P. Fernyhough, L. T. Diemel et al.: Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci. 17 (1994) 321-325
51. Bonica, J. J.: The Management of Pain, 2. ed. Lea and Febiger, Philadelphia (1990)
52. Coderre, T. T. J., J. Katz, A. L. Vaccarino et al.: Contribution of central neuroplasticity to pathological pain: review of clinical experimental evidence. Pain 52 (1993) 259-285
53. Dickenson, A.: Novel Pharmacological targets in the treatment of pain. Pain Rev. 2 (1995) 1-12
54. Jänig, W., M. Stanton-Hicks: Reflex Sympathetic Dystrophy - a Reappraisal. Progress in Pain Research and Management. Vol. 6. IASP Press, Seattle (1996)
55. Lewin, G. R., L. M. Mendell: Nerve growth factor and nociception. TINS 16 (1993) 353-359
56. Meller, S. T., G. F. Gebhart: Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52 (1993) 127-136